CROWN BIOSCIENCE
Live / Applied — Fourth extension granted (statement of use) (as of 17 Feb 2026)
What this means for you
Not registered yet, but its 13 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97409044
- Mark type
- Design + words
- Filed
- 13 May 2022
- Published for opposition
- 12 Dec 2023
- Attorney of record
- Yi Zhang
Goods and services
- Class 009 — Scientific and electric apparatus: (Based on Use in Commerce) Downloadable computer application software for mobile phones, namely, software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Downloadable computer software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Downloadable mobile applications for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Downloadable software in the nature of a mobile application for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data
- Class 031 — Natural agricultural products: (Based on Intent to Use) Live animals; Live animals, namely, rodent animal, specifically, rats; Live laboratory animals
- Class 042 — Scientific and technological services: (Based on Use in Commerce) Consulting services in the field of biotechnology; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical laboratory services; Medical research services in the field of cancer; Pharmaceutical drug development services; Providing a members-only website featuring technology which provides members with the ability to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a secured-access, members only website featuring technology that gives members the ability to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a web site featuring technology that enables users to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a website featuring non-downloadable software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a website featuring on-line non-downloadable software that enables users to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a website featuring resources, namely, non-downloadable software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Scientific and technological services, namely, analyzing preclinical oncology efficacy in the field of medical treatment; Scientific laboratory services; Scientific research for medical purposes in the area of cancerous diseases; Technical research in the field of pharmaceutical studies
- Class 044 — Medical, beauty and agricultural services: (Based on Use in Commerce) Drug use screening services; Drug use testing services; Drug, alcohol and DNA screening for medical purposes; Medical screening; Medical services, namely, pre-employment drug screening; Providing information in the field of cancer prevention, screening, diagnosis and treatment
Owner
- Crown Bioscience, Inc., San Diego, CA, US
- Crown Bioscience, Inc., San Diego, CA, US
Prosecution history
- 17 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Feb 2026 — SOU EXTENSION 4 GRANTED
- 05 Feb 2026 — SOU EXTENSION 4 FILED
- 06 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 30 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Sept 2025 — SOU EXTENSION 3 GRANTED
- 05 Aug 2025 — SOU EXTENSION 3 FILED
- 11 Sept 2025 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 11 Sept 2025 — NOTICE OF REVIVAL - E-MAILED
- 11 Sept 2025 — PETITION TO REVIVE-GRANTED
- 11 Sept 2025 — TEAS PETITION TO REVIVE RECEIVED
- 08 Sept 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 Sept 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 06 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Feb 2025 — SOU EXTENSION 2 GRANTED